BenevolentAI
Davy Suvee serves as the Head of Technology and holds various senior positions at BenevolentAI since October 2016, including SVP of Technology and SVP of Product Management. Suvee is the founder and Manager of Datablend, offering Big Data and NoSQL consultancy since June 2011. Additionally, Suvee has been an Independent Expert/Evaluator for H2020 and the Seventh Research Framework Programme at the European Union since February 2013. Roles also include Product Manager at Ferret.ai since February 2015, Big Data Architect at Stratified Medical from September 2014 to September 2016, IT Project Lead at Tibotec-Virco (Johnson & Johnson) from January 2009 to June 2013, and Analyst/Developer at CTG Belgium from October 2006 to December 2008. Academic involvement includes Assistant/Researcher at the System and Software Engineering Lab at Vrije Universiteit Brussel from September 2002 to September 2006, supported by a doctoral scholarship from the Flemish Institute for the Improvement of the Scientifical-Technological Research in the Industry. Davy Suvee holds a degree from Vrije Universiteit Brussel obtained between 1998 and 2002.
This person is not in any teams
This person is not in any offices
BenevolentAI
8 followers
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, discovering a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.